BSECompany Update2d ago · 29 Jul 2026, 06:38 pm
As Attached
Eris Lifesciences Ltd · 540596
✦ AI SummaryResults
Eris Lifesciences Ltd has announced the availability of the earnings conference call recording for the quarter ended June 30, 2026, on its website.
Analysis Scores
Earnings Impact8/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk5/10
Liquidity Impact9/10
Market Sentiment6/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Eris Lifesciences Ltd - 540596 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Attachments (1)
📄pdf
Download →
42fded81-0bb3-4e21-9c6c-9797e60c5a05.pdf
View document text
Date: 29 July 2026
To To
BSE Limited National Stock Exchange of India Limited
Phiroze Jeejeebhoy Towers Exchange Plaza
Dalal Street Bandra Kurla Complex
Mumbai – 400001 Bandra (E)
Mumbai – 400051
Security Code: 540596 Symbol: ERIS
SUBJECT: RECORDING OF THE EARNINGS CONFERENCE CALL ON THE UNAUDITED
CONSOLIDATED AND STANDALONE FINANCIAL RESULTS OF THE COMPANY FOR THE
QUARTER ENDED JUNE 30, 2026
Dear Sir/Madam,
In accordance with the applicable requirements and regulations of the Securities and Exchange Board of
India (Listing Obligations and Disclosure Requirements) Regulations, 2015 and other applicable
regulations, we hereby inform you that the Recording of the Earnings Conference Call in connection with
the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter ended June
30, 2026, held on July 29, 2026, is available on the website of the Company and can be accessed through
the following link:
Link: https://eris.co.in/financials/
(File name: Q1 FY27-Earnings Call Recording)
Thanking You,
For Eris Lifesciences Limited
Milind Talegaonkar
Company Secretary & Compliance Officer
ICSI Mem. No.: A26493